Related Experiment Video

Updated: Mar 8, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.3K

Abdominal aortic dissection during sorafenib therapy for hepatocellular carcinoma

Lin Xu1, Boqing Wang1, Wei Ding1

  • 1Department of Hepatopancreatobiliary Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830000, China.

Clinics and Research in Hepatology and Gastroenterology
|February 7, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.3K
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.3K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.3K
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.8K

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

556
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
556
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

422
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
422

Articles linked to this work by shared authors, journal, and citation graph.

Application of robotic-assisted hepatopancreatoduodenectomy in non-jaundiced gallbladder cancer patient with invasion of the common bile duct: A case report.

Medicine·2026

Diagnostic Performance of Serum AKR1B10 in Early-Stage and AFP-Negative Hepatocellular Carcinoma: A Multicentre Study.

Liver international : official journal of the International Association for the Study of the Liver·2026

[Mechanism of irisin in alleviating sepsis-associated acute kidney injury by inhibiting ferroptosis via the Nrf2/HO-1 signaling pathway].

Zhonghua wei zhong bing ji jiu yi xue·2026

A Large-Scale Retrospective Study of Serum Des-Gamma-Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity.

Journal of clinical laboratory analysis·2025

RNA binding motif protein 25 is a negative prognostic biomarker and promotes cell proliferation via alternative splicing in hepatocellular carcinoma.

Pathology, research and practice·2025

GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma.

Pharmacological research·2024

Management of portal vein thrombosis in cirrhosis: Risks, treatments, and outcomes of a retrospective multicenter study with over 10 years of follow-up.

Clinics and research in hepatology and gastroenterology·2026

Safety and effectiveness of GLP-1 receptor agonists and SGLT-2 inhibitors in liver transplant recipients with diabetes.

Clinics and research in hepatology and gastroenterology·2026

Efficacy and safety of empagliflozin in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.

Clinics and research in hepatology and gastroenterology·2026

Squamous cell anal carcinoma: Current therapeutic approaches.

Clinics and research in hepatology and gastroenterology·2026

From one-size-fits-all to on-demand: personalized crispr gene editing for rare genetic liver diseases.

Clinics and research in hepatology and gastroenterology·2026

Sarcopenia in decompensated cirrhosis: a comparative analysis of bioelectrical impedance-based measures.

Clinics and research in hepatology and gastroenterology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us